[ACL] QoQ Quarter Result on 31-Mar-2023 [#Q3]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
30-Mar-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q3]
Profit Trend
QoQ- -79.39%
YoY- -78.18%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 333,719 168,634 336,760 168,380 360,312 180,156 457,603 -18.93%
PBT 7,806 3,903 15,554 7,777 32,756 16,378 69,956 -76.72%
Tax 2,731 1,366 4,994 2,497 7,274 3,637 21,842 -74.90%
NP 4,952 2,476 10,480 5,240 25,421 12,711 48,030 -77.92%
Tax Rate -34.99% -34.99% -32.11% -32.11% -22.21% -22.21% -31.22% -
Total Cost 328,767 166,158 326,280 163,140 334,891 167,446 409,573 -13.59%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 1.48 1.47 3.11 3.11 7.06 7.06 10.50 -72.81%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 0.02 0.01 0.05 0.03 0.13 0.06 0.24 -80.83%
EPS Diluted 0.02 0.01 0.05 0.03 0.13 0.06 0.24 -80.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.